Work on the thromboplastic activity of human platelets necessitated the preparation of platelet concentrates. As a preliminary step, platelet-rich plasma was obtained by slow centrifugation of oxalated or citrated whole blood. Subsequently, it was observed that the supernatant plasma of citrated blood appeared more opalescent and yielded a larger platelet mass than did that derived from oxalate blood. Although citrate and oxalate are commonly used in collecting blood for coagulation studies, no information on such a difference was found in the available literature. More precise quantitative work was necessary to confirm this finding.
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The investigation described in this communication was performed to decide whether citrate was superior to oxalate for the purpose of separating the maximal numbers of platelets from blood collected into these two anticoagulants.
Materials and Methods
Collection of the Blood.-Venous blood was collected from the antecubital veins of clinically healthy adult volunteers of both sexes, using 20 ml. paraffined glass syringes and size 18 needles. A clean, rapid venipuncture was usually performed, but when difficulty was encountered the aspirated blood was discarded. Nine millilitres of blood from the sx ringe was immediately transferred to two siliconed conical graduated centrifuge tubes, one containing ml. of sodium citrate and the other 1 ml. of potassium oxalate. Each tube was then gently inverted thre2 times.
Potassium Oxalate.-( (COOK)2.H20) 0.1 M (1.840o). Sodium Citrate.-(Na3CfjH5O7.2H2O) 0.13 M (3.8°o). These concentrations of anticoagulant are generally recommended for coagulation studies (Holbum, 1955 A few crystals Platelet-rich Plasma.-Immediately after setting up the whole blood platelet counts the tubes were centrifuged in a horizontal M.S.E. centrifuge at 1.000 r.p.m. for 10 minutes. The oxalated supernatant plasma was usually less opalescent than that of the citrated samples.
Buffy Coat Smears.-With a Pasteur pipette, a small amount of the buffv coat from each centrifuged sample was removed. The buffy coat was usually more prominent in the oxalated samples. Smears were made from this material, dried, and stained with Leishman's stain.
All the work was done at room temperature.
Results Fifteen blood samples obtained from different persons were examined. The results are shown in Table I . It is clear that the whole blood counts of the oxalated and citrated samples do not differ significantly.
In striking contrast, the plasma counts show a relatively wide difference. All the citrated samples had a higher platelet concentration. In most instances, the oxalated plasma counts were lower than those of the corresponding whole blood, whereas all the citrated plasma counts were greater than those of the corresponding whole EFFECT OF OXALATE AND CITRATE ON PLATELET COUNT blood. The mean value of the citrated plasma counts was almost three times greater than that of the oxalated plasma. The plasmas with the lowest platelet counts appeared relatively translucent. Suspecting that the reduced counts in the oxalated plasma might be the result of their reduced suspension stability during centrifugation, the buffy coats of the two samples were examined. This demonstrated that the oxalated buffy coat contained large numbers of platelets compared with the relatively few in the citrated buffy coat (Fig. 1) .
Discussion
A precise quantitative investigation therefore demonstrated that the plasma from oxalated blood had a lower platelet concentration than that of the same blood collected into citrate, although the whole blood concentrations in the two samples were almost identical. 
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The presence of large numbers of platelets in the buffy coat of the oxalated blood compared with the relatively few platelets in that from the citrated blood strongly suggests that the suspension stability on centrifugation of the oxalated platelets is reduced, or conversely that the citrated platelets have a greater suspension stability under these conditions. The reason for this difference is not immediately apparent. The answer may well be found in the difference in their action as anticoagulants. Both exert their action by combining with the calcium in the blood, the oxalate by a direct precipitation, thus removing the calcium completely from solution, and the citrate by forming a complex with the calcium, which, however, remains in solution. This precipitating effect of oxalate on calcium can be easily demonstrated with pure solutions, when a definite cloudiness can be seen after the addition of oxalate to a calcium solution. But no visible change can be observed when the citrate is added in equivalent amount to the solution of calcium.
There is evidence (Cohn, 1953; Odell and Upton, 1955 ) that some calcium is adsorbed on to the platelets. A possible explanation of the oxalate effect may be, therefore, that it forms a plateletcalcium-oxalate complex, as a result of which the suspension stability of the platelet is decreased, this becoming manifest when the blood is slowly centrifuged. Since citrate does not precipitate the calcium, it might be expected, by the same reasoning, that the platelet suspension stability in citrate would not be reduced.
Factor V declines in oxalated but not in citrated stored plasma (Quick and Stefanini, 1948) . The possibility arises that this difference between the anticoagulants might also be related to their different actions on calcium. Complete removal of calcium by oxalate might disrupt a factor V-calcium complex. Maintenance of the complex might be necessary for the activity and stability of factor V. The experimental findings of Stefanini (1950) For separating maximum numbers of platelets from blood by centrifugation, citrate was found to be a better anticoagulant than oxalate. The lower concentration of platelets found in the oxalated plasma is thought to be related to the decreased suspension stability of the platelets resulting from combination of the oxalate with their adsorbed calcium.
